Aspect Clinical
Ledbury, United Kingdom
NCT Number: NCT02158481
The main aim of the study is to investigate the effects of dietary ingredients (polyphenols and carotenoids) on vascular function during acute glucose load. Each subject will receive 4 weeks of intervention with test product or placebo product after a dietary restriction run-in period of 14 days. Subjects will be challenged with an oral glucose tolerance test (OGTT) immediately after the run-in phase and at the end of the intervention phase. During the OGTT, blood samples will be taken at regular intervals.
The study will be conducted in subjects with impaired glucose tolerance.
Looking for future studies?
Notify Me35 year–65 year
All sexes
Interventional
Not applicable
Ledbury, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placebo intervention
Time frame: At baseline (after 2 weeks run-in period) and after 4 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 4 weeks intervention
Time frame: At baseline (after 2 weeks run-in period) and after 4 weeks intervention
Time frame: At baseline (after run-in period of 2 weeks) and after 4 weeks intervention
Unilever R&D
Industry
Investigating the Effects of Dietary Ingredients on Vascular Function During Acute Glucose Load
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02439775
Cardiovascular Diseases, Hypertension
Huntsville, Alabama, United States
View Trial DetailsNCT04664478
Abnormal Elastogenesis, Aortic Stenosis, Supravalvular
Bethesda, Maryland, United States
View Trial DetailsNCT03626688
Cardiovascular Diseases, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06069102
Cardiovascular Diseases, Eclampsia
Pittsburgh, Pennsylvania, United States
View Trial Details